Should You Buy RB Global Inc (RBA) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Hold
Latest Price
113.570
1 Day change
-1.20%
52 Week Range
119.580
Analysis Updated At
2026/01/30
Not a good buy right now for an impatient investor. While the longer-term trend structure is still bullish (SMA_5 > SMA_20 > SMA_200) and fundamentals are improving, near-term momentum is weakening (MACD histogram below zero and negatively expanding) and the pattern-based forecast points to downside risk over the next month (-8.65%). With no Intellectia buy signals today and price still below the pivot (114.769), the setup is not attractive for an immediate entry.
Technical Analysis
Price/levels: RBA at 113.24 is below the pivot (114.769) and sitting just above first support S1 (112.325). A clean break below ~112.3 increases risk toward S2 (110.814). To regain near-term strength, it likely needs to reclaim the pivot (~114.8) and then challenge R1 (117.214).
Trend: Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), suggesting the broader trend remains up.
Momentum: MACD histogram is negative (-0.0866) and expanding to the downside, signaling weakening momentum. RSI_6 at 42.7 is neutral-to-soft (not oversold), implying there may be room for further drift lower before a momentum reset.
Quant/pattern read: Similar candlestick-pattern analysis implies modest next-day upside (+1.01%) but weakness over the next week (-0.8%) and especially next month (-8.65%), which undermines an “buy-now” decision for a short-horizon trader.
Intellectia Proprietary Trading Signals
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Options positioning looks bullish: put/call ratios are very low (OI PCR 0.12; volume PCR 0.31), implying call-heavy sentiment. Implied vol (30d) ~27.79 vs historical vol ~27.55 is roughly in-line (no obvious fear premium). IV percentile ~57 suggests mid-range pricing, but IV rank ~6.63 indicates IV is low relative to its own recent range—more consistent with calm/optimistic positioning than stress. Note: sentiment is constructive, but options are relatively thin today (21 contracts total), so signal strength is moderate.
Technical Summary
Sell
2
Buy
8
Positive Catalysts
on 2026-02-17 after hours could become a catalyst if results/guide are strong.
Neutral/Negative Catalysts
is close to BofA’s $114 target, reducing “quick win” upside unless momentum improves.
Financial Performance
Latest quarter: 2025/Q3. Growth trends were solid: Revenue $1.0927B (+11.30% YoY), Net Income $80.7M (+20.63% YoY), EPS $0.43 (+19.44% YoY). Gross margin improved to 34.68 (+1.14 YoY). Overall, this is a constructive growth/efficiency profile, but the current trade decision is constrained by weakening near-term technical momentum.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent changes are net positive. National Bank upgraded to Outperform (PT raised to $124 from $111) and explicitly framed the selloff as a buying opportunity. BofA kept a Buy but trimmed PT to $114 from $120, citing valuation methodology and auto-related overhangs while still sounding increasingly positive into 2026.
Wall Street pros: improving setup into 2026, willingness to buy dips, and raised target by one firm.
Wall Street cons: valuation/multiple pressure and overhang commentary; near-term PT from BofA is essentially at today’s price.
Influential/political trading: No recent congress trading data available; insiders show no significant recent trend (neutral).
Wall Street analysts forecast RBA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RBA is 127 USD with a low forecast of 114 USD and a high forecast of 137 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
Wall Street analysts forecast RBA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RBA is 127 USD with a low forecast of 114 USD and a high forecast of 137 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
0 Hold
0 Sell
Strong Buy
Current: 114.950
Low
114
Averages
127
High
137
Current: 114.950
Low
114
Averages
127
High
137
National Bank
Sector Perform -> Outperform
upgrade
$111 -> $124
AI Analysis
2025-11-23
Reason
National Bank
Price Target
$111 -> $124
AI Analysis
2025-11-23
upgrade
Sector Perform -> Outperform
Reason
National Bank upgraded RB Global to Outperform from Sector Perform with a price target of $124, up from $111. The firm views the recent selloff in the shares as a buying opportunity.
BofA
Michael Feniger
Buy
downgrade
$120 -> $114
2025-11-07
Reason
BofA
Michael Feniger
Price Target
$120 -> $114
2025-11-07
downgrade
Buy
Reason
BofA analyst Michael Feniger lowered the firm's price target on RB Global to $114 from $120 and keeps a Buy rating on the shares. The firm rolls forward its valuation methodology a year and applies a slightly lower multiple on some auto overhangs, but adds that it sees RB as "perhaps too conservative" and says it is increasingly positive on the set up into 2026.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for RBA
